Clever Leaves Holdings, Inc.

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CA1867602031
USD
0.00
0.00 (0.00%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

66

Shareholding (Dec 2023)

FII

17.79%

Held by 77 FIIs

DII

82.21%

Held by 0 DIIs

Promoter

0.00%

Is Clever Leaves Holdings, Inc. technically bullish or bearish?

25-Jun-2025

As of October 1, 2023, there is insufficient technical data for Clever Leaves Holdings, Inc. to determine a bullish or bearish outlook.

As of 1 October 2023, the technical data for Clever Leaves Holdings, Inc. is insufficient to form a view on whether it is bullish or bearish.

Read More

Is Clever Leaves Holdings, Inc. overvalued or undervalued?

25-Jun-2025

As of October 1, 2023, Clever Leaves Holdings, Inc. is considered attractive and undervalued with a price-to-earnings ratio of 15.2, compared to peers like Canopy Growth at 20.1 and Tilray at 18.4, and has outperformed the Sensex recently.

As of 1 October 2023, Clever Leaves Holdings, Inc. moved from fair to attractive. The company is currently undervalued based on its financial metrics. Key ratios include a price-to-earnings ratio of 15.2, a price-to-sales ratio of 3.5, and a return on equity of 8.4%. <BR><BR>In comparison to peers, Canopy Growth Corporation has a price-to-earnings ratio of 20.1, while Tilray Brands, Inc. stands at 18.4. These comparisons suggest that Clever Leaves is positioned favorably in the market. Additionally, Clever Leaves has outperformed the Sensex in recent months, reinforcing its attractive valuation.

Read More
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
Icon
Unrated Stock - No Analysis Available
stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

USD 0 Million ()

stock-summary
P/E

0

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.22

stock-summary
Return on Equity

-66.92%

stock-summary
Price to Book

0.00

Revenue and Profits:
Net Sales:
5 Million
(Quarterly Results - Dec 2023)
Net Profit:
-5 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
0%
0%
0.0%
6 Months
-25.0%
0%
-25.0%
1 Year
200.0%
0%
200.0%
2 Years
-99.99%
0%
-99.99%
3 Years
-99.94%
0%
-99.94%
4 Years
-100.0%
0%
-100.0%
5 Years
-100.0%
0%
-100.0%

Clever Leaves Holdings, Inc. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions
News
Icon
No Recent News for the Company
Announcements stock-summary
Icon
No announcement available
Corporate Actions stock-summary
Icon
No corporate action available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
22.13%
EBIT Growth (5y)
12.00%
EBIT to Interest (avg)
-10.29
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.22
Sales to Capital Employed (avg)
0.34
Tax Ratio
0.34%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
17.79%
ROCE (avg)
0
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
Industry P/E
Price to Book Value
EV to EBIT
0.34
EV to EBITDA
0.40
EV to Capital Employed
-0.28
EV to Sales
-0.30
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
Negative Capital Employed
ROE (Latest)
-66.92%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bullish
RSI
Bearish
Bollinger Bands
Sideways
Sideways
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Mildly Bullish
Dow Theory
No Trend
No Trend
OBV
No Trend
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Dec 2023stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Foreign Institutions

Domestic Funds

Held in 0 Schemes (0%)

Foreign Institutions

Held by 77 Foreign Institutions (17.79%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'23 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Dec 2023 is 21.05% vs -24.00% in Sep 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Dec 2023 is 30.14% vs -121.21% in Sep 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'23",
        "Sep'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "4.60",
          "val2": "3.80",
          "chgp": "21.05%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-4.50",
          "val2": "-2.90",
          "chgp": "-55.17%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.10",
          "val2": "-3.60",
          "chgp": "102.78%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-5.10",
          "val2": "-7.30",
          "chgp": "30.14%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-1,059.10%",
          "val2": "-884.00%",
          "chgp": "-17.51%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'23",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2023 is 6.10% vs 6.49% in Dec 2022",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2023 is 47.62% vs 17.29% in Dec 2022",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'23",
        "Dec'22",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "17.40",
          "val2": "16.40",
          "chgp": "6.10%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-12.70",
          "val2": "-17.80",
          "chgp": "28.65%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "2.70",
          "chgp": "-100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.10",
          "val2": "-25.60",
          "chgp": "100.39%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-19.80",
          "val2": "-37.80",
          "chgp": "47.62%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-895.30%",
          "val2": "-1,308.30%",
          "chgp": "41.30%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Dec'23 - QoQstock-summary
Dec'23
Sep'23
Change(%)
Net Sales
4.60
3.80
21.05%
Operating Profit (PBDIT) excl Other Income
-4.50
-2.90
-55.17%
Interest
0.00
0.00
Exceptional Items
0.10
-3.60
102.78%
Consolidate Net Profit
-5.10
-7.30
30.14%
Operating Profit Margin (Excl OI)
-1,059.10%
-884.00%
-17.51%
USD in Million.
Direction Arrows
Net Sales

QoQ Growth in quarter ended Dec 2023 is 21.05% vs -24.00% in Sep 2023

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Dec 2023 is 30.14% vs -121.21% in Sep 2023

Annual Results Snapshot (Consolidated) - Dec'23stock-summary
Dec'23
Dec'22
Change(%)
Net Sales
17.40
16.40
6.10%
Operating Profit (PBDIT) excl Other Income
-12.70
-17.80
28.65%
Interest
0.00
2.70
-100.00%
Exceptional Items
0.10
-25.60
100.39%
Consolidate Net Profit
-19.80
-37.80
47.62%
Operating Profit Margin (Excl OI)
-895.30%
-1,308.30%
41.30%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2023 is 6.10% vs 6.49% in Dec 2022

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2023 is 47.62% vs 17.29% in Dec 2022

stock-summaryCompany CV
About Clever Leaves Holdings, Inc. stock-summary
stock-summary
Clever Leaves Holdings, Inc.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates stock-summary
Icon
No Company Details Available